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Abstract
The intracellular distribution of swine vesicular disease virus (SVDV) proteins and the induced reorganization of endomembranes in IBRS-2 cells
were analyzed. Fluorescence to new SVDV capsids appeared first upon infection, concentrated in perinuclear circular structures and colocalized to
dsRNA. As in foot-and-mouth disease virus (FMDV)-infected cells, a vesicular pattern was predominantly found in later stages of SVDV capsid
morphogenesis that colocalizedwith those of non-structural proteins 2C, 2BC and 3A. These results suggest that assembly of capsid proteins is associated
to the replication complex. Confocal microscopy showed a decreased fluorescence to ER markers (calreticulin and protein disulfide isomerase), and
disorganization of cis-Golgi gp74 and trans-Golgi caveolin-1 markers in SVDV- and FMDV-, but not in vesicular stomatitis virus (VSV)-infected cells.
Electron microscopy of SVDV-infected cells at an early stage of infection revealed fragmented ER cisternae with expanded lumen and accumulation of
large Golgi vesicles, suggesting alterations of vesicle traffic through Golgi compartments. At this early stage, FMDV induced different patterns of ER
fragmentation and Golgi alterations. At later stages of SVDV cytopathology, cells showed a completely vacuolated cytoplasm containing vesicles of
different sizes. Cell treatment with brefeldin A, which disrupts the Golgi complex, reduced SVDV (∼5 log) and VSV (∼4 log) titers, but did not affect
FMDV growth. Thus, three viruses, which share target tissues and clinical signs in natural hosts, induce different intracellular effects in cultured cells.
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Swine vesicular disease virus (SVDV) is a member of the
genus Enterovirus within the family Picornaviridae and it is
assumed to be derived from the human pathogen coxsackievirus
B5 (CVB5) (Zhang et al., 1993, 1999). SVDV is the aetiological
agent of an important and highly contagious disease of pigs☆ Dedicated to the memory of Rosario Armas-Portela.
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doi:10.1016/j.virol.2007.12.042(SVD). Outbreaks have periodically affected Europe and East
Asia (Brocchi et al., 1997; Knowles et al., 2007; Lin andKitching,
2000) since SVDwas first reported in Italy in 1966 (Nardelli et al.,
1968). In contrast to human coxsackievirus, which are the
responsible for myocarditis, pancreatitis and meningitis (Whitton
et al., 2005), SVDV tropism is related to epithelial tissues (Mulder
et al., 1997). Since SVDV and CVB are able to use the same
cellular receptors (Jimenez-Clavero et al., 2005), differences in
viral tropismmay be a consequence of post-entry factors (Whitton
et al., 2005). The vesicular lesions produced by SVDV are
indistinguishable from those caused by foot-and-mouth disease
virus (FMDV), another picornavirus that belongs to the genus
Aphthovirus (Rowlands, 2003; Sobrino and Domingo, 2004),
Fig. 1. SVDV, FMDV and VSV efficiently infect IBRS-2 cells. A) Single step
growth curve of the three viruses. IBRS-2 cells were infected (MOI of 0.5) and at
different times PI supernatant virus yield was determined by plaque assay.
B) Time-course of accumulation of SVDV proteins in infected cells. Mock and
SVDV-infected cells (as in A) were lysed and viral proteins were detected by
Western-blotting using rabbit polyclonal antisera against the N-terminus of
SVDV VP1, and to 2BC or 3A proteins from CVB3. Cellular β-actin is shown
as control of protein loading. Expected protein molecular weights (in kDa): VP1
(31.6), 2C (37.3), 2BC (48.3), P2 (64.7), 3A (9.89) and 3AB (12.3).
C) Representative examples of immunofluorescence patterns of infected cells.
Infected cells (MOI of 0.5) were processed for immunofluorescence at 8 h PI,
using MAbs 2H12, SD6 and I1 to detect SVDVor FMDVVP1 proteins or VSV-
G protein, respectively, and a secondary antibody coupled to Alexa Fluor 594.
Bar: 20 μm.
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Vesiculovirus, family Rhabdoviridae (Letchworth et al., 1999;
Lin and Kitching, 2000). Although SVDV does not usually
produce a severe disease, the need for a differential diagnosis with
FMD makes this virus important for international trade as reflec-
ted by its inclusion in the list of diseases notifiable to the OIE.
SVDV and FMDV genomes are composed of a single-
stranded RNA molecule of positive polarity that is translated
using an internal ribosome entry site (IRES) to produce a
polyprotein. This polyprotein is then processed into mature viral
proteins (Belsham and Martínez-Salas, 2004; Escribano-
Romero et al., 2000; Zhang et al., 1993). The four structural
proteins (VP1–VP4) conform an icosahedral capsid of approxi-
mately 25–30 nm in diameter. Seven non-structural (NS)
proteins (and some of their precursors) are implicated in viral
cycle: 2A, 2B, 2C, 3A, 3B, 3C and 3D, plus L protein in the case
of FMDV (Buenz and Howe, 2006; Whitton et al., 2005).
Among them, L, 2A and 3C are the proteases that catalyze
polyprotein processing to yield mature viral proteins. 3D is an
RNA dependent RNA polymerase and 3B (VPg) is a peptide
which links covalently to the 5′ end of viral genome. The SVDV
genome encodes a single copy of 3B gene. Three tandem copies
are present in the FMDVRNA (Forss et al., 1984). Hydrophobic
domains for membrane anchor are predicted for 2B, 2C and 3A
proteins (Echeverri and Dasgupta, 1995; Towner et al., 1996;
van Kuppeveld et al., 1996; Wessels et al., 2006c).
Studies performed mainly with poliovirus (PV) have revealed
that picornavirus RNA replication takes place at the surface of
cytoplasmic vesicles derived from cellular membranes of
endoplasmic reticulum (ER) and the Golgi complex (Bienz
et al., 1987; Garcia-Briones et al., 2006; Knox et al., 2005;
O'Donnell et al., 2001; Schlegel et al., 1996; Suhy et al., 2000).
Picornavirus infection impairs protein trafficking along the
secretory pathway (Cornell et al., 2006; Doedens and Kirkegaard,
1995; Moffat et al., 2005) and inhibits host cell protein and RNA
synthesis (Ehrenfeld, 1982;Holland, 1962). The differences in the
morphology of cytoplasmic vesicles induced in infected cells and
in the sensitivity to the Golgi disrupting agent brefeldin A (BFA)
suggest diverse cellular requirements among picornaviruses to
build the replication complex (Gazina et al., 2002; Moffat et al.,
2005; Monaghan et al., 2004; Wessels et al., 2006a).
Although SVDV was described forty years ago, most aspects
of its interaction with host cells remain undetermined and they
are assumed to be similar to those described for other entero-
viruses, mainly PV. In this study, we have performed a com-
parative analysis of the reorganizations induced by SVDV
infection on the ER and Golgi architecture by using confocal
and electron microscopy analyses. The alterations found were
compared with those produced by two important animal
vesicular viruses: FMDV and VSV, the effects induced in
cultured cells by the latter being well established (Letchworth et
al., 1999). Experiments were performed in a cell line IBRS-2
susceptible to these three viruses. Our results support that
SVDV infection disassembles the ER and the Golgi and that
viral replication takes place at the surface of cytoplasmic
vesicles likely originated from these cell structures. The
alterations induced by FMDV were in part similar to those
434 M.A. Martín-Acebes et al. / Virology 374 (2008) 432–443caused by FMDV, while VSV did not disassemble ER or Golgi
complex. Differences were also found in the sensitivity to BFA
as it did not affect FMDV growth, but highly inhibited SVDVand VSV infections. Overall, these results suggest differential
requirements to build the replication complex among the three
viruses studied.
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SVDV, FMDV and VSV infect IBRS-2 cells
Each of the viruses studied productively grew in IBRS-2
cells (Fig. 1A), showing a parallel time-course and producing a
morphologically similar cytopathic effect (data not shown).
When the time-course of SVDV protein detection was studied
by Western-blotting, a protein band of the expected size was
revealed by the antibody to N-ter of VP1. The protein band
recognized by antibody N-ter was first detected at 6 h PI, being
more intense at 8 h PI (Fig. 1B). Antiserum to 2BC from the
related CVB3 recognized SVDV 2C, 2BC and P2 precursor at
8 h PI. This antibody did not recognize protein 2B as described
(Cornell et al., 2006). Similar results were obtained using an
anti-CVB3 2C antibody (data not shown). Likewise, the anti-
body to CVB3 3A detected, from 6 h PI, a protein band which
size corresponded to that of SVDV 3A and an additional band
of a mobility compatible with that of precursor 3AB (Fig. 1B).
The Western-blot detection of the SVDV proteins analyzed was
delayed when compared to FMDV-infected cells (Fig. S1 in
Supplementary data, and data not shown). Fluorescence studies
were performed at 8 h PI of cells infected with a low MOI of
about 0.5, which allowed detection of cells with different
degrees of infection progress for the three viruses compared.
Infected cells showed specific fluorescence to epitopes exposed
in mature viral capsids, corresponding to the structural protein
VP1 for SVDV (2H12) and FMDV (MAb SD6) or to the G
glycoprotein for VSV (MAb I1), and representative images are
shown in Fig. 1C. In average, emergence of fluorescence was
delayed in SVDV-infected cells (from 4–5 h PI) when
compared to cells infected with FMDV or VSV (from 2.5 to
3 h PI) (data not shown). Fluorescence to MAb 2H12 in
SVDV-infected cells showed a vesicular perinuclear pattern
combined with a cytoplasmic granular distribution. As
described for other FMDV-infected cell lines (Garcia-Briones
et al., 2006; Knox et al., 2005), VP1 distribution in IBRS-2
infected cells was more diffuse and appeared concentrated in
smaller vesicles with a preferential perinuclear location
(Garcia-Briones et al., 2006; Monaghan et al., 2004). In
VSV-infected cells, G protein accumulated perinuclearly and
also at the cell periphery. A similar distribution was reported
for BHK-21 infected cells (Arnheiter et al., 1984). This
distribution likely corresponds to part of the ER and Golgi
complexes and the plasma membrane where newly synthesized
virions acquire their envelope (de Silva et al., 1990; Odenwald
et al., 1986).Fig. 2. Subcellular distribution of fluorescence to immature and mature capsids and
immunofluorescence patterns shown by IBRS-2 cells infected with SVDV (8 h PI). C
(red) and MAb 2H12 (green). Images were ordered to represent different stages of inf
of the amino acids contributing to the epitopes recognized by antibody N-ter and M
accession number:1mqt), created using oligomer generator at Viperdb (Shepherd et al.
by MAb 2H12 (Borrego et al., 2002), is indicated in green; the sequence of the 20 N-
Clavero et al., 2001). VP1 (blue), VP2 (white), VP3 (magenta) and VP4 (yellow). C)
to 2C or 3A CVB3 proteins (red) in combination with MAb 2H12 to VP1 (green), o
merged images.Intracellular location of SVDV capsid proteins
Two antibodies that recognized epitopes differentially
exposed in SVDV capsid intermediates were used to study the
emergence and location of capsid proteins in infected cells.
Antibody to the N-terminus of VP1 recognizes an internal
epitope that only becomes accessible following the conforma-
tional rearrangements induced by the interaction of the virion
with cell receptors (Jimenez-Clavero et al., 2001). N-ter also
reacts with denatured SVDV VP1 protein in Western-blotting
(Fig. 1B), suggesting that this antibody is able to detect unfolded
forms of SVDV capsid precursors. On the other hand,MAb2H12
recognized a discontinuous epitope that is exposed in mature
capsids and virions at later stages of viral morphogenesis
(Borrego et al., 2002; Jimenez-Clavero et al., 2001) (Fig. 2A).
Fig. 2B shows the location on a SVDV capsid pentamer model of
the VP1 residues used to produce antibody N-ter, and of the VP1
residue where replacements in mutants escaping neutralization
by MAb 2H12 were found (Borrego et al., 2002). Double
immunofluorescence labelling experiments performed at 8 h PI in
SVDV-infected cells (MOI of 0.5), allowed detection of SVDV-
infected cells positive for antibody N-ter that did not show
fluorescence to the discontinuous epitope recognized by MAb
2H12 (Fig. 2A). This fluorescence was considered to corre-
spond to capsid precursors antigenically similar to the modified
virions generated following the interaction with cell receptors,
termed immature capsids. In cells showing this early pattern,
fluorescence of antibody N-ter was concentrated in perinuclear
circular structures, including “ring-like” images that likely
corresponded to the surface of vesicles where de novo capsid
protein synthesis takes place. As infection progressed, an
increase in a perinuclear and granular cytoplasmic accumula-
tion of fluorescence to the discontinuous epitope recognized by
MAb 2H12 was observed and colocalized to antibody N-ter.
Concomitantly, a fading and more diffuse staining with
antibody N-ter was observed (see merge images in Fig. 2A).
In order to confirm that these patterns represented different
infection stages, we performed infections at high MOI, in an
attempt to synchronize infection, and fixed cells at defined time
intervals. Cells showing only fluorescence for N-ter antibody
accounted for 80% of the total positive cells at 3.5 h PI. This
ratio drastically reduced from 5 h PI, when at least 90% of
positive cells showed fluorescence to MAb 2H12 (Fig. S2,
Supplementary data). Remarkably under these experimental
conditions not all the cells in the culture showed equal levels of
protein accumulation and cytopathic effect, confirming the
asynchronous progress of SVDV infection. In some instancesto NS proteins in SVDV-infected cells. A) Confocal sections of representative
ells were infected (MOI of 0.5) and immunostained using rabbit antiserum N-ter
ection, based on the relative intensity of fluorescence to MAb 2H12. B) Location
AB 2H12 on a SVDV capsid pentamer model (Verdaguer et al., 2003) (PDB
, 2006). The VP1 residue Asp 85, functionally involved in the epitope recognized
terminal VP1 residues used to produce antibody N-ter is shown in red (Jimenez-
Confocal sections of cells infected and processed as in (A), using polyclonal sera
r MAb J2 to dsRNA (green). Yellow fluorescence denotes colocalization in the
Fig. 3. SVDV, FMDVor VSV infection induces different effects on ER. Optical
sections of IBRS-2 cells infected with SVDV, FMDVor VSV (MOI of 0.5) and
processed for double immunofluorescence, at 8 h PI, using rabbit polyclonal
antiserum to calreticulin or MAb 1D3 to PDI and the corresponding virus-specific
antibodies 2H12, SD6 and I1 or N-ter and VP1, respectively. A) Changes in ER
pattern fluorescence induced by SVDV infection. B) FMDV infection disperses
and decreases ER fluorescence. C) Changes in the ER pattern fluorescence induced
by VSV infection. Asterisks denote infected cells.
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to MAb 2H12 at ring-like structures of lower size than those
observed with antibody N-ter (Fig. S4, Supplementary data).
Similar results were obtained in double immunofluorescences
combining antibody N-ter andMAb 5C4; the latter recognizing
a conformational epitope only exposed in mature SVDV
capsids, for which mutants escaping neutralization showed
mutations at VP3 protein (Borrego et al., 2002) (Fig. S3,
Supplementary data).
SVDV capsids assemble close to replication site
SVDV NS proteins were detected by antibodies specific for
CVB3 2C, 2BC and 3A (Fig. 2C and Fig. S5A in Supplementary
data). These proteins were mainly located perinuclearly and
exhibited a punctuated pattern. Their fluorescence colocalized
with that of mature capsids recognized by MAb 2H12,
suggesting that SVDV capsid maturation occurred close to the
replication complex as described for other picornaviruses (Egger
et al., 2000; Krogerus et al., 2003). This possibility was
supported by double labelling experiments with a MAb to
dsRNA whose accumulation at the replication complexes built
by other picornaviruses has been reported (Gazina et al., 2002).
The confocal sections analyzed showed a punctuated perinuclear
pattern corresponding to dsRNA in SVDV-infected cells, but not
in mock-infected cells (Fig. 2C and Fig. S5B in Supplementary
data). Fluorescence to dsRNA colocalized with SVDV NS
proteins 2B, 2BC and 3A, as well as with immature capsids
recognized by antibody N-ter.
Alterations induced on ER and Golgi morphology by SVDV
infection
Picornavirus replication takes place associated to cellular
membranes (see Introduction), so we investigated the effects of
SVDV infection on the ER and Golgi structures and compared
them with those produced by FMDV and VSV. Infected cells
which showed major morphological effects were not considered
in these analyses as these alterations impaired recognition and
comparison of cell structures. Confocal microscopy of SVDV-
infected cells using antibodies to ER markers showed decreased
fluorescence intensity against calreticulin and PDI when
compared with mock-infected cells (Fig. 3A). A parallel
decrease in fluorescence to PDI was observed in FMDV-
infected cells, while the calreticulin pattern was shown
perinuclearly dispersed (Fig. 3B). Conversely, in VSV-infected
cells, calreticulin staining appeared perinuclearly concentrated
(Fig. 3C). In this case the intensity of the fluorescence allowed
the analysis of thinner sections that revealed the colocalization
of VSV-G protein and calreticulin.
SVDV infection of IBRS-2 cells dispersed and reduced the
fluorescence intensity to the cis-Golgi complex marker gp74
(Fig. 4A). This Golgi alteration was also observed in FMDV-
infected cells (Fig. 4B), as previously described for BHK-21
infected cells (Garcia-Briones et al., 2006). Likewise the
perinuclear accumulation of caveolin-1, a protein that resides
at the trans-Golgi and cycles through caveolae at plasmamembrane (Kurzchalia et al., 1994), was also dispersed in
SVDVand FMDV-infected cells confirming the ER disruption.
In contrast, VSV infection did not alter the caveolin-1 staining
pattern of the Golgi (Fig. 4C).
Fig. 4. SVDV, FMDVor VSV infection induces different effects on the Golgi.
Optical sections of IBRS-2 cells infected with SVDV, FMDVor VSV (MOI of
0.5) and processed for double immunofluorescence, at 8 h PI, using MAb 25H8
to gp74 (cis-Golgi marker) or anti-caveolin-1 rabbit polyclonal serum (trans-
Golgi marker) and the corresponding virus-specific antibodies 2H12, SD6 and
I1 or N-ter and VP1, respectively. A) Golgi dispersion induced by SVDV
infection. B) FMDV infection disperses Golgi. C) VSV infection does not alter
Golgi staining pattern. Asterisks denote infected cells.
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The differences in the alterations induced at the ER and
Golgi complexes by the infection of IBRS-2 cells with SVDVor
FMDV were further analyzed by TEM. Infections were per-
formed at high MOI and cells were analyzed when the cyto-
pathic effect was evident: 6 h PI for FMDVand 8 h PI for SVDV
(Fig. 5). Two populations of SVDV-infected cells could be
distinguished. One with cells exhibiting a low cytopathic effect,
and a second population defined by rounded cells showing
advanced cytopathic effect that was assumed to correspond to
late stages of infection. In cells presenting low cytopathic effect
(Fig. 5A) it was possible to identify the different cell com-
partments. As reported for BHK-21 cells (Monaghan et al.,
2004), two populations of FMDV-infected IBRS-2 cells could
be identified. Those that exhibited low cytopathology and those
with an advanced cytopathology that detached from the plates.
Thus, a comparative study of the changes on intracellular
architecture induced by SVDV and FMDV was performed
among the attached cells showing low cytopathic effect. These
SVDV-infected cells exhibited fragmented ER cisternae with an
expanded lumen, while FMDV-infected cells were character-
ized by longer and not so swollen cisternae (Fig. 5A). On the
other hand, abundant and larger vesicles were identified near the
Golgi complex in SVDV-infected cells suggesting that infection
altered vesicle traffic through Golgi compartments. In FMDV-
infected cells abundant vesicles were also found besides the
presence of swollen cisternae (Fig. 5A).
At later stages of SVDV infection, cells with an advanced
cytopathic effect showed a completely vacuolated cytoplasm
that impaired identification of any vestige of ER or Golgi com-
plex (Fig. 5Ba). Two populations of vesicles could be dis-
tinguished. One included vesicles with more than 100 nm in
diameter (Fig. 5Ba1) and a second population integrated by
smaller vesicles, tightly clustered (Fig. 5Ba2). Double mem-
brane vesicles were identified in the two populations, beingmore
frequently found among the smaller vesicles. In some cases,
cells demonstrating advanced cytopathic effect (Fig. 5Bb)
exhibited a whole vacuolated cytoplasm, including long dilated
cisternae and clustered vesicles. Breaking up cellular nuclei
suggests that apoptosis could also take place in these cells
(Fig. 5Ba). Thus, electrodense circular inclusions observed in
the cytoplasm (Fig. 5Ba and b), would be more likely remnants
of cell nuclei than virus containing bodies.
Treatment with BFA differentially affects the infection of
IBRS-2 cells by SVDV, FMDV or VSV
BFA, a Golgi disrupting agent, affects picornavirus replica-
tion differentially (Gazina et al., 2002; Maynell et al., 1992;
Monaghan et al., 2004; O'Donnell et al., 2001; Pietiainen et al.,
2004) so we evaluated the effects of BFA on SVDV, FMDVand
VSV infection (Fig. 6). As reported for NRK cells (Alcalde
et al., 1994), BFA caused on IBRS-2 cells a rapid dispersion of
the cis-Golgi marker gp74 (Fig. 6A), which indicates Golgi
disruption. VSV infection of HeLa cells is very sensitive to
Golgi disruption by BFA, since it depends on the function of the
Fig. 5. Ultrastructural alterations in SVDVand FMDV-infected cells. IBRS-2 cells were infected with SVDV (MOI of 40) or FMDV (MOI of 3), fixed after 8 h and 6 h
PI, respectively, and the ultrastructure of Golgi and the ER was examined by TEM. The figure shows representative images of: A) Golgi and ER rearrangements in
infected cells presenting low cytopathic effect. B) Ultrastructure of SVDV-infected cells presenting two stages of advanced cytopathic effect (a,b). Areas of interest are
magnified in a1 and a2. N: cell nucleus; white arrowheads: swollen ER cisternae; black arrows: vesicles near Golgi complex; white arrows: swollen Golgi cisternae;
black arrowheads: double membrane vesicles; asterisks: long dilated cisternae; black bars: 100 nm, white bars: 5 μm.
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Oda et al., 1990). This was also observed in IBRS-2 cells treated
with BFA that showed a decrease in the virus yield (about 4 log)
and in the percentage of infected cells (90%) (Fig. 6B). A higher
inhibition of the virus yield (about 5 log) was found after SVDV
infection and no infected cells could be detected by immuno-
fluorescence staining. Similar reductions of SVDV yield were
found when BFAwas added from 3 h PI. This confirmed that the
inhibition exerted by with this drug, which can also affect virus
entry (Pietiainen et al., 2004; Sieczkarski and Whittaker, 2002),
was mostly affecting post-internalization stages of virus
replication (data not shown). Conversely, FMDV infection
and virus yield were not inhibited by the BFA treatment of
IBRS-2 cells (Fig. 6B), as reported for other FMDV-infected
cell lines (Monaghan et al., 2004; O'Donnell et al., 2001). No
differences in the VP1 staining pattern between BFA-treated or
untreated FMDV-infected cells were noticed (Fig. 6C). In
contrast, upon VSV infection fluorescence to G proteinappeared dispersed in BFA-treated cells, reflecting its retention
at the ER. The inhibition of SVDV infectivity by BFA
correlated with a lack of capsid protein detection by Western-
blotting. This was not observed in BFA-treated cells following
FMDV infection (Fig. 6D).
Thus, BFA affects differentially the yield of infection of the
three viruses compared and shows no effect in FMDV-infected
IBRS-2 cells.
Discussion
The study of the molecular mechanisms exploited by different
viruses to produce similar pathologies in natural hosts is
challenging and can provide valuable information to understand
virus–host interactions. The intracellular aspects of in vivo
pathogenesis are complex since not only the viral receptor/s but
also the subsequent interactions between the virus and host cells
are relevant for the final outcome of infections (Domingo et al.,
Fig. 6. Effects of Golgi disruption induced by BFA on SVDV, FMDVor VSV infection. A) BFA causes Golgi dispersion. IBRS-2 cells treated for 30 min. with BFA
(5 μg/ml) or DMSO (control cells) were immunostained using MAb 25H8 to the cis-Golgi marker gp74. B) Effects of BFA treatment on SVDV, FMDV and VSV
infection. BFA-treated and non-treated cells were infected (MOI of 0.5). At 8 h PI, the total virus yield and the percentage of infected cells (relative to untreated cells)
were determined by plaque assay and by immunofluorescence using MAbs 2H12 (SVDV VP1), SD6 (FMDV VP1) and I1 (VSV-G), respectively. Asterisks denote
statistically significant differences (ANOVA: pb0.05). C) Representative immunofluorescence micrographs corresponding to SVDV, FMDVand VSV-infected cells.
Cells were infected and processed for immunofluorescence as described in (B). Infected cells for which enlargements are included are shown boxed. Bar: 20 μm.
D) Western-blot analysis of SVDVand FMDV production in BFA-treated cells. Infected cells, treated or not with the drug, were lysed at 8 h PI. A lysate from infected
control cells (1 h PI) was also included. Western-blotting was performed as described in Materials and methods and membranes were incubated with the rabbit
polyclonal antiserum N-ter (SVDV) or with MAb SD6 (FMDV). Membranes incubated with an anti-β-actin antibody were included as a control for protein loading.
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analysis of specific aspects of virus infection in cultured cells,
such as the compartmentalization of virus gene expression and
the reorganization of cell structures, is a useful tool. Here, wehave attempted such kind of analyses by using the three viruses
causing the main vesicular diseases of domestic animals. The
SVDVanalyzed in this study is a field isolate that enter cultured
cells using the coxsackievirus and adenovirus receptor (CAR)
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Clavero et al., 2005). The FMDVand VSV compared here enter
cultured cells using integrins or phosphatidyl serine as receptors,
respectively (Baranowski et al., 1998; Jackson et al., 2000;
Schlegel et al., 1983). Upon serial passages in cultured cells
FMDV can acquire the ability to enter cells via heparan sulfate
(Baranowski et al., 1998; Jackson et al., 1996). SVDV, FMDV
andVSV similarly infect IBRS-2 cells, a porcine-derived cell line
widely used for SVDV and FMDV growth and characterization
(Burman et al., 2006; Jimenez-Clavero et al., 2001). The time-
course of virus yield was similar between SVDV and FMDV.
However, the detection of capsid andNS proteinswas delayed for
SVDV (Fig. 1). Even when a lower sensitivity in Western-
blotting and immunofluorescence of the different SVDV
antibodies used cannot be excluded, these results suggest a
delayed accumulation of SVDV proteins relative to those
observed in FMDV-infected cells.
Fluorescence to antibody N-ter was detected first upon
infection. This suggests that an early step in capsid protein
synthesis and assembly occur at large, circular structures,
interpreted as spherical vesicles, localized close to the nucleus.
As infection proceeded, fluorescence to the mature capsids
recognized by MAb 2H12 became predominant and showed
lower size and a distribution pattern similar to that observed in
FMDV-infected cells (Fig. 2A), while N-ter staining faded.
Further experiments are required to understand the capsid
modifications mediating these observations. However, these
results suggest that immature capsids expose the N-terminus of
VP1 and that mature SVDV capsids displaying discontinuous
epitopes present in mature virions, mainly accumulate at
vesicles with a different average morphology and location
than those initially associated to immature capsids.
The colocalization of immature capsids and NS proteins with
discrete cumuli of dsRNA suggests that SVDV capsid synthesis
and assembly occur associated to the replication complex. This
colocalization is also observed between NS proteins and mature
capsids, indicating that capsid maturation also associates to the
replication complex. These findings are consistent with the
coupled viral RNA replication and translation reported to occur
for other picornaviruses at the surface of cytoplasmic vesicles
originated from membranes derived from ER and Golgi (Egger
et al., 2000; Krogerus et al., 2003).
Immunofluorescence studies also showed that SVDV and
FMDV disassembled ER and Golgi complexes. Disruption of
the ER by FMDV was slightly lower than that induced by
SVDV (Figs. 3 and 4). The dispersion of ER and Golgi markers
impaired colocalization analyses with SVDV and FMDV
proteins (data not shown). Disruption of the Golgi complex
has been previously reported for different picornaviruses
including FMDV (Cornell et al., 2006; Garcia-Briones et al.,
2006; O'Donnell et al., 2001; Sandoval and Carrasco, 1997),
and the reorganization of ER by 2B protein has also been
observed in enterovirus infected cells (van Kuppeveld et al.,
1997). These alterations at ER and Golgi complexes induced by
picornaviruses inhibit MHC-I molecules secretion to the cell
surface (Deitz et al., 2000; Sanz-Parra et al., 1998), and may
contribute to evade host immune response. As expected fromthe VSV requirement for an intact secretory pathway (de Silva
et al., 1990; Irurzun et al., 1993; Oda et al., 1990), VSV-infected
cells did not show alterations of ER and Golgi.
SVDV-infected cells showed by TEM a high proportion of
double membrane vesicles and clusters of small membrane-
associated vesicles. These structures were not frequently ob-
served in FMDV-infected cells, as described (Monaghan et al.,
2004). The differences in the endomembrane reorganizations
induced by SVDV and FMDV (Fig. 5) may reflect differential
cellular requirements in the organization of the replication
complex, such as those reported among different picornaviruses
for the cellular components of COP-I coat (Gazina et al., 2002).
BFA blocks ADP ribosylation factor 1 (Arf1) by inhibiting
specific guanine nucleotide exchange factors (GEFs) involved
in recycling of inactive GDP-bound to active GTP-bound
forms. Since these factors are required for COP-I retrograde
vesicle transport between Golgi and ER complexes, BFA causes
Golgi disruption and redistribution of Golgi markers to the ER
(Belov et al., 2007; Jackson and Casanova, 2000). BFA
inhibited efficiently SVDV infection (one log higher than
VSV multiplication) as described for other enteroviruses
(Gazina et al., 2002; Maynell et al., 1992). Conversely, BFA
did not inhibit FMDV replication, as reported for BHK cells
infected with type O and A FMDVs (Monaghan et al., 2004;
O'Donnell et al., 2001).
In PV, 3A and 3CD have been shown to mediate translocation
of specific Arfs and their GEFs – GBF1 and BIG1/2,
respectively –, which are susceptible for BFA inhibition
(Belov et al., 2007, 2005; Niu et al., 2005). In addition, BFA-
resistant PV mutants carried mutations in 2C and 3A proteins
(Crotty et al., 2004), which also indicates a possible role for 2C
protein in membrane recruiting. The sensitivity to BFA observed
for SVDV infection (Fig. 6) suggests a role for BFA-susceptible
GEFs in the membrane recruiting induced by this virus. On the
other hand, 3A protein from CVB3, a close relative to SVDV,
can interact with GBF1 blocking Arf-1 mediated COP-I
assembly and causing protein transport blockage (Wessels et
al., 2006b). This is also observed for PV but not for FMDV 3A
proteins (Wessels et al., 2006a). Thus, the differential effect of
BFA on SVDVor FMDV replication suggests differences in the
capacity of their 3A proteins to interact with GEFs.
Autophagy and COP-II dependent transport, which are not
inhibited by BFA (Belov et al., 2005), have been also implicated
in the intracellular vesicle formation induced by PV and other
picornaviruses (Jackson et al., 2005; Rust et al., 2001; Schlegel
et al., 1996; Suhy et al., 2000). The double membrane structures
observed in Fig. 5 might indicate an autophagy origin of part of
the vesicles induced in SVDV-infected cells. The contribution
of autophagy and COP-II dependent transport to FMDV
membrane recruitment remains to be clarified.
Overall, the results reported here suggest that despite being
able to infect similar epithelia and to produce undistinguishable
lesions in natural hosts (Alexandersen and Mowat, 2005;
Cornish et al., 2001; Mulder et al., 1997), SVDV and FMDV
utilize different mechanisms to build their replication complex,
and that these mechanisms share little in common to that used
by the rhabdovirus VSV.
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Cells and viruses
The two cell lines employed in this study were IBRS-2 (De
Castro, 1964) derived from swine kidney, and BHK-21 derived
from Syrian golden hamster kidney (Macpherson and Stoker,
1962). Both cell lines were maintained in Dulbecco's modified
Eagle's medium (DMEM) (Gibco-BRL) supplemented with 5%
fetal calf serum (FCS) (Sigma), L-glutamine (2 mM), penicillin
(100 U/ml) and streptomycin (100 μg/ml). The SVDV isolate
SPA/1/'93 (Jimenez-Clavero et al., 1998) was propagated on
IBRS-2 cells. Viral stocks from type C FMDV C-S8c1 (Sobrino
et al., 1983) and VSV Indiana serotype isolates were produced
by amplification in BHK-21 cells.
Antibodies and reagents
SVDV mature capsids were visualized using MAb 2H12 and
5C4 (Borrego et al., 2002). A rabbit polyclonal antiserum to a
synthetic peptide spanning the 20 N-terminal residues of VP1
(Jimenez-Clavero et al., 2001) was used to detect this protein in
Western-blotting assays or when incorporated as part of
immature capsids (fluorescence assays). FMDV VP1 was
detected by MAb SD6, which recognizes a continuous epitope
exposed in viral capsids (Mateu et al., 1987), or by a rabbit
polyclonal antiserum (Strebel et al., 1986). VSV-G glycoprotein
was detected using mouse MAb I1 (Lefrancois and Lyles,
1982). Rabbit polyclonal antisera against coxsackievirus B3
(CVB3) NS proteins 2BC, 3A (Cornell et al., 2006) and 2C
(Whitton et al., unpublished results) were employed for SVDV
NS protein detection. cis and trans-Golgi networks were stained
using MAb 25H8 to gp74 (Alcalde et al., 1994) or a polyclonal
rabbit antiserum to caveolin-1 (BD Transduction Laboratories),
respectively. Calreticulin rabbit polyclonal antiserum (Abcam)
and MAb 1D3 against protein disulfide isomerase (PDI)
(Stressgene) were used for ER staining, and MAb AC-15
(Sigma) was employed to detect β-actin. MAb J2 (English &
Scientific Consulting) was employed to detect double-stranded
RNA (dsRNA). Alexa Fluor 488 (green) and 594 or 555 (red)
conjugated anti-mouse or anti-rabbit secondary antibodies
(Invitrogen) were used to recognize primary antibodies in
immunofluorescence assays. For Western-blotting, anti-rabbit
or anti-mouse horseradish peroxidase (HRP)-coupled secondary
antibodies (GE Healthcare) were utilized. A stock solution
(20 mg/ml) of BFA (Sigma) was prepared in DMSO.
Infections and virus titrations
Cells were washed twice with DMEM and infected with
different multiplicities of infection expressed as PFU/cell
(hence MOI). After 1 h adsorption, inoculum was removed
and fresh medium containing 5% FCS was added. This time-
point was considered 1 h post-infection (PI). For BFA treatment,
the drug was added to cultures 30 min before infection, and it
was maintained during the whole infection time to avoid cellular
recuperation. The virus released in infection medium and thetotal virus produced (intracellular and medium-released,
recovered by three freeze–thaw cycles) were quantified as
PFU/ml by plaque assay (Sobrino et al., 1983). FMDVand VSV
titers were obtained in BHK-21 (at 24 h PI), while SVDV titers
were determined in IBRS-2 cells (at 48 h PI).
Immunofluorescence and confocal microscopy
Infected cells, grown on coverslips, were fixed with 4%
paraformaldehyde or in cold absolute methanol for cis-Golgi
staining, and processed for immunofluorescence assays as
reported (Garcia-Briones et al., 2006). Nuclei were counter-
stained with 1 μg/ml DAPI (Molecular Probes) or with To-Pro-3
(Molecular Probes) and samples were examined using an
Olympus BX61 epifluorescence microscope coupled to a digital
cooled charge-coupled-device (CCD) camera DP70 (Olympus).
Images were acquired using Olympus DP controller software.
For confocal laser scanning microscopy, images were collected
using an Axiovert S100 TV microscope (Zeiss) equipped with a
confocal Radiance 2000 system (Bio-Rad) and acquired using
Lasersharp2000 5.2 software (Bio-Rad). Sequential scanning for
different laser lines was performed to avoid false colocalization
and images were processed using Adobe Photoshop 7.0.1
(Adobe Systems Inc.).
Transmission electron microscopy (TEM)
Mock or infected cell monolayers, grown on 100 mm Ø
dishes, were washed 3 times with PBS and fixed 30 min at
37 °C in 4% paraformaldehyde-2% glutaraldehyde in 0.1 M
sodium cacodylate buffer pH 7.4 supplemented with 5 mM
CaCl2. Cells were scrapped and postfixed in 1% osmium
tetroxide-1% potassium ferricyanide for 1 h at 4 °C, washed
three times with bidistilled water and treated with 0.15% tanic
acid in phosphate buffer pH 7.4 for 1 min. Cells were washed
with the buffer and with bidistilled water prior to the staining
with 2% uranyl acetate for 1 h at RT. After three washes with
bidistilled water samples were dehydrated in ethanol and
embedded in TAAB 812 resin (TAAB laboratories, Berkshire,
UK). Samples were examined using a Jeol JEM-1010 electron
microscope (Jeol, Japan) operating at 80 kV and images were
acquired using a digital camera Bioscan792 (Gatan, Inc. 5933
Coronado Lane, Pleasanton, CA 94588).
Western-blot assay
Infected cells, grown on 35 mm Ø dishes, were lysed and
their proteins resolved on SDS-PAGE and transferred to a
nitrocellulose membrane, as described (Garcia-Briones et al.,
2006). Membranes were blocked with 3% skimmed milk in
PBS, washed with PBS-0.5% Tween and incubated over night
at 4 °C with the primary antibody diluted in PBS-1% BSA.
After washing with PBS-0.5% Tween, membranes were
incubated with appropriated secondary antibody coupled to
HRP in PBS-1% BSA for 1 h at RT, and washed with PBS-0.5%
Tween. Proteins were detected by using Western Lighting
Chemiluminiscence Reagent (Perkin Elmer).
442 M.A. Martín-Acebes et al. / Virology 374 (2008) 432–443Data analysis
Analysis of the variance (ANOVA), using F Fischer–
Snedecor distribution, was performed with statistical package
SPSS 13.0 (SPSS Inc.) for Windows.
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